磁括约肌增强术适应证放宽:体重指数是否影响疗效
该多中心回顾性队列研究纳入2016至2019年在三家高手术量中心接受腹腔镜磁括约肌增强术(MSA)的621例胃食管反流病(GERD)患者,按世界卫生组织体重指数(BMI)分类分为四组比较结局。结果显示,正常体重、超重与肥胖患者组间结局无显著差异,各组抗酸药物使用均显著减少、GERD-HRQL评分低、DeMeester评分低、术中与术后并发症少、食管裂孔疝复发率低。
要点
- BMI>35组女性更多、术前DeMeester评分中位数更高。
- 正常体重、超重与肥胖组间MSA结局无显著差异。
- 各组抗酸药物使用均显著减少、食管裂孔疝复发率低。
核心结论
- MSA在改善GERD症状、降低食管酸暴露和预防食管裂孔疝复发方面安全有效,且不受患者BMI影响。
- 作者认为,MSA应被视为肥胖GERD患者可接受的治疗选择。
研究设计与样本
- 研究为回顾性队列研究,纳入2016至2019年在三家高手术量中心连续接受腹腔镜MSA的患者。
- 共621例患者接受腹腔镜MSA;361例(58%)有内镜或视频食管造影随访,中位随访15.4个月。
- 按世界卫生组织BMI分类分为四组:BMI<25为正常体重,BMI 25-29.9为超重,BMI 30-34.9为肥胖I级,BMI>35为肥胖II-III级。
主要发现
- BMI>35组女性更多,且术前DeMeester评分中位数更高;其余基线特征各组相似。
- 正常体重、超重与肥胖患者组间MSA结局无显著差异。
- 所有组均出现抗酸药物使用显著减少、GERD-HRQL评分低、DeMeester评分低、术中与术后并发症少及食管裂孔疝复发率低。
临床怎么用
- 作者认为,MSA应被视为肥胖GERD患者可接受的治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Magnetic sphincter augmentation (MSA) is an effective treatment for gastroesophageal reflux disease (GERD). However, the impact of obesity on MSA outcomes is unknown. The objective of this study was to evaluate the effectiveness of MSA in patients with GERD and obesity. METHODS: A retrospective cohort study was performed of consecutive patients who underwent laparoscopic MSA at three high-volume centers from 2016 to 2019. Patients were grouped into four cohorts according to the World Health Organization body mass index (BMI) classification: BMI < 25 (normal weight), BMI 25-29.9 (overweight), BMI 30-34.9 (obese class I), and BMI > 35 (obese class II-III). Preoperative, operative, and postoperative data were compared between groups. RESULTS: A total of 621 patients underwent laparoscopic MSA during the study period. Follow-up with endoscopy or video esophagram was available for 361 patients (58%) with a median follow-up of 15.4 months. Baseline characteristics of the groups were similar except the BMI > 35 group had more females and a higher preoperative median DeMeester score. There were no significant differences in outcomes between normal weight, overweight, and obese patient groups undergoing MSA. All groups experienced significant reductions in acid suppressive medication use, low GERD-HRQL scores, low DeMeester scores, few intraoperative and postoperative complications, and low rates of hiatal hernia recurrence after MSA. CONCLUSIONS: Magnetic sphincter augmentation is safe and effective in improving GERD symptoms, reducing esophageal acid exposure, and preventing hiatal hernia recurrence, irrespective of patient BMI. MSA should be considered an acceptable treatment option for obese patients with GERD.
引用
- James TJ, Burke JF, Putnam LR, et al. Loosening the belt on magnetic sphincter augmentation indications: does body mass index matter? Surg Endosc. 2021. PMID: 34750701. doi:10.1007/s00464-021-08839-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。